$186 Million is the total value of SABBY MANAGEMENT, LLC's 93 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AKAOQ | Exit | ACHAOGEN INC | $0 | – | -134,192 | -100.0% | -0.00% | – |
| FCEL | Exit | FUELCELL ENERGY INC | $0 | – | -17,640 | -100.0% | -0.00% | – |
| SINT | Exit | SINTX TECHNOLOGIES INC | $0 | – | -84,655 | -100.0% | -0.01% | – |
| KTOV | Exit | KITOV PHARMA LTDads | $0 | – | -14,500 | -100.0% | -0.02% | – |
| SGLBW | Exit | SIGMA LABS INC*w | $0 | – | -65,033 | -100.0% | -0.03% | – |
| SPHS | Exit | SOPHIRIS BIO INC | $0 | – | -52,685 | -100.0% | -0.06% | – |
| Exit | APPLIED DNA SCIENCES INCput | $0 | – | -390 | -100.0% | -0.10% | – | |
| APDNW | Exit | APPLIED DNA SCIENCES INC*w | $0 | – | -21,504 | -100.0% | -0.11% | – |
| CALA | Exit | CALITHERA BIOSCIENCES INC | $0 | – | -28,806 | -100.0% | -0.14% | – |
| APOP | Exit | CELLECT BIOTECHNOLOGY LTDads | $0 | – | -243,563 | -100.0% | -0.16% | – |
| UMRX | Exit | UNUM THERAPEUTICS INC | $0 | – | -50,922 | -100.0% | -0.17% | – |
| Exit | AETERNA ZENTARIS INCput | $0 | – | -501 | -100.0% | -0.17% | – | |
| ISR | Exit | ISORAY INC | $0 | – | -370,612 | -100.0% | -0.19% | – |
| AVEO | Exit | AVEO PHARMACEUTICALS INC COM | $0 | – | -281,112 | -100.0% | -0.24% | – |
| OPGN | Exit | OPGEN INC | $0 | – | -519,341 | -100.0% | -0.26% | – |
| RMTI | Exit | ROCKWELL MED INC | $0 | – | -72,059 | -100.0% | -0.27% | – |
| CODX | Exit | CO DIAGNOSTICS INC | $0 | – | -279,595 | -100.0% | -0.28% | – |
| HEB | Exit | HEMISPHERX BIOPHARMA INC | $0 | – | -60,858 | -100.0% | -0.34% | – |
| SCON | Exit | SUPERCONDUCTOR TECHNOLOGIES | $0 | – | -467,900 | -100.0% | -0.48% | – |
| EMAN | Exit | EMAGIN CORP | $0 | – | -861,903 | -100.0% | -0.49% | – |
| SLS | Exit | SELLAS LIFE SCIENCES GROUP INC | $0 | – | -3,926,022 | -100.0% | -0.56% | – |
| STOK | Exit | STOKE THERAPEUTICS INC | $0 | – | -16,202 | -100.0% | -0.60% | – |
| CANF | Exit | CAN FITE BIOPHARMA LTD | $0 | – | -211,896 | -100.0% | -0.77% | – |
| BCLI | Exit | BRAINSTORM CELL THERAPEUTICS INC | $0 | – | -158,152 | -100.0% | -0.79% | – |
| Exit | WAVE LIFE SCIENCES LTDcall | $0 | – | -552 | -100.0% | -1.81% | – | |
| SHIPW | Exit | SEANERGY MARITIME HOLDINGS CORP*w | $0 | – | -965,000 | -100.0% | -1.94% | – |
| AMPE | Exit | AMPIO PHARMACEUTICALS INC | $0 | – | -5,265,265 | -100.0% | -2.57% | – |
| Exit | BIOGEN INCcall | $0 | – | -410 | -100.0% | -12.06% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.